Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multicenter Evaluation of the Safety and Effectiveness of the EMBLOK Embolic Protection System During Transcatheter Aortic Valve Replacement

NCT05295628 is registered in ClinicalTrials.gov with Emblok, Inc. as lead sponsor.

NCT NCT05295628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05295628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multicenter Evaluation of the Safety and Effectiveness of the EMBLOK Embolic Protection System During Transcatheter Aortic Valve Replacement
Lead sponsor
Emblok, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 17, 2023
Completion date
October 1, 2025
Enrollment
532 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve disease, aortic valve insufficiency, aortic valve replacement, aortic valve stenosis